ABBV Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
17.4B
+2.4%
17.0B
+13.3%
15.0B
-9.7%
16.6B
+5.3%
15.8B
Cost of Revenue
4.3B
-0.1%
4.3B
+1.7%
4.2B
-7.3%
4.6B
-14.2%
5.3B
Gross Profit
13.1B
+3.3%
12.7B
+17.8%
10.8B
-10.6%
12.1B
+15.2%
10.5B
Operating Expenses
6.9B
+9.3%
6.3B
-7.8%
6.8B
-12.2%
7.7B
-9.7%
8.6B
R&D
2.6B
+9.5%
2.3B
-5.2%
2.5B
-4.1%
2.6B
+11.2%
2.3B
SG&A
4.1B
+12.5%
3.6B
+1.5%
3.6B
-8.1%
3.9B
+9.1%
3.6B
Operating Income
6.3B
-2.6%
6.4B
+61.2%
4.0B
-7.8%
4.3B
+127.3%
1.9B
EBITDA
8.3B
-3.0%
8.6B
+29.0%
6.7B
-12.0%
7.6B
+14.0%
6.6B
Net Income
4.2B
+16.7%
3.6B
+418.8%
697.0M
-61.6%
1.8B
+865.4%
188.0M
EPS (Basic)
$2.38
+16.7%
$2.04
+423.1%
$0.39
-61.8%
$1.02
+920.0%
$0.10
EPS (Diluted)
$2.37
+16.7%
$2.03
+420.5%
$0.39
-61.8%
$1.02
+920.0%
$0.10
Shares (Diluted)
1.8B
+0.1%
1.8B
-0.2%
1.8B
-0.2%
1.8B
+0.3%
1.8B
ABBVIE (ABBV) — Financials